chief-executive

Pentagon eyes proposal for M&A changes in ‘weeks’

By Andrea Shalal WASHINGTON (Reuters) – The Pentagon and other U.S. government agencies should complete a legislative proposal in coming weeks to let regulators block proposed mergers for national security reasons, instead of just antitrust concerns, a top official said on Tuesday. Defense Undersecretary Frank Kendall, who oversees arms weapons acquisitions and industrial base issues for the Pentagon, made the comments in an interview, after first …

Read the rest here:
Pentagon eyes proposal for M&A changes in ‘weeks’

chief-executive

Turing Pharma seeks CEO to replace Shkreli, plans job cuts

Shkreli, 32, resigned as CEO on Friday, a day after his arrest on charges that he had engaged in a Ponzi-like scheme. On Monday, KaloBios Pharmaceuticals said Shkreli was “terminated” as CEO and had resigned from the board. Turing did not specify the number of job cuts in a statement.

Go here to read the rest: 
Turing Pharma seeks CEO to replace Shkreli, plans job cuts

chief-executive

Ericsson signs patent deal with Apple, shares soar

Swedish mobile telecom gear maker Ericsson said it had signed a patent license deal with Apple Inc over technology that helps smartphones and tablets connect to mobile networks, sending its shares up much as 8 percent. The deal ends a year-long dispute with Apple, one of the biggest legal battles in mobile technology and Ericson said…

Originally posted here:
Ericsson signs patent deal with Apple, shares soar

chief-executive

KaloBios fires Shkreli as CEO

(Reuters) – Drugmaker KaloBios Pharmaceuticals Inc said it fired Martin Shkreli as chief executive on Dec. 17, the day he was arrested on charges of a securities fraud. Shkreli, who has become the poster child for the issue of soaring prices for prescription medications, has already stepped down as CEO of private drugmaker Turing Pharmaceuticals Inc, in addition to resigning from KaloBios' board of directors. Shkreli was arrested last week for engaging in what U.S. prosecutors said was a Ponzi-like scheme at his former hedge fund MSMB Capital …

Read more here: 
KaloBios fires Shkreli as CEO

chief-executive

Raytheon awarded $2.35 billion contract for SM-3 missiles

Raytheon Co has won a contract worth up to $2.35 billion to build 52 SM-3 Block IB missiles for the U.S. Missile Defense Agency using fiscal 2015 funding, plus three one-year options, the Pentagon said on…

Original post: 
Raytheon awarded $2.35 billion contract for SM-3 missiles

chief-executive

Turing Pharma names chairman to replace Shkreli as CEO

(Reuters) – Martin Shkreli, the poster boy for prescription drug price increases who was arrested for securities fraud this week, has stepped down from his post as chief executive officer of Turing Pharmaceuticals Inc, the company said on Friday. Shkreli was replaced by Turing Chairman Ron Tilles, who said in a statement that the company was committed to continuing…

View original post here:
Turing Pharma names chairman to replace Shkreli as CEO

chief-executive

The Fed Awakens

Barring a shock, the Federal Reserve will raise U.S. interest rates on Wednesday for the first time since June 2006, a full year before the global financial crisis began. Data releases will meanwhile give clues to the robustness of other economies, some of which are seen as vulnerable to

Here is the original:
The Fed Awakens

chief-executive

Dow, DuPont set $130 billion megamerger, could spark more deals

Dow and DuPont shares fell on Friday after spiking earlier in the week following reports of negotiations. Executives from both companies said the agrichemicals businesses have little overlap and any asset sales would likely be minor. Dow shareholders would own 52 percent of the new company after preferred shares are converted, the companies said.

Excerpt from:
Dow, DuPont set $130 billion megamerger, could spark more deals

chief-executive

Dow Chemical, DuPont in merger talks: sources

Dow Chemical Co and DuPont are in talks to merge, creating a chemicals giant with a market value of more than $120 billion that could then break up into different businesses, people familiar with the matter said on Tuesday. Following what would be structured as a merger of equals, the combined company could split into material sciences, specialty products and agrochemicals, the people said, cautioning that the…

Originally posted here: 
Dow Chemical, DuPont in merger talks: sources

chief-executive

Fairly upbeat U.S. data highlight economy’s resilience

By Lucia Mutikani WASHINGTON (Reuters) – New U.S. applications for unemployment benefits fell last week while a gauge of U.S. economic activity rebounded in October, signs of a healthy labor market and economy that could give the Federal Reserve confidence to raise interest rates next month. Outside manufacturing, the economy has remained resilient despite faltering global growth. “Business rolls on unperturbed …

Read the original:
Fairly upbeat U.S. data highlight economy’s resilience

« Previous Page — Next Page »